CompaniesDuoning Biotechnology

Duoning Biotechnology

active
Shanghai, China
Founded 2005
Website
About

Bioprocess Solutions

Areas of Focus

Categories

Non-PharmaceuticalChina
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

45

By Phase

PHASE1/PHASE2: 1PHASE1: 1

By Status

ENROLLING_BY_INVITATION: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT04540770
NCT07210047
Hover over trial bars to see details

Recent Trials

NCT07210047Lead Sponsor
Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients
PHASE1/PHASE2Enrolling by invitation
21 participants
Started: Aug 18, 2025 · Completed: Jan 31, 2028
NCT04540770Lead Sponsor
A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001
PHASE1Completed
24 participants
Started: Aug 31, 2021 · Completed: Jan 19, 2024
Locations (1)
Headquarters
Shanghai, China
Map

Loading map...